Sun, Yuanqing
Ma, Wei
Xu, Tao
Zheng, Jing
Article History
Received: 4 December 2023
Accepted: 9 August 2024
First Online: 27 August 2024
Declarations
:
: This prospective, double-blind, sequential dose-finding study was approved by the China Ethics Committee of Registering Clinical Trials (ChiECRCT20200191). The study was registered prior to patient enrolment at (registration number: ChiCTR2000035465) on August 12, 2020. Written informed consent was obtained from all study participants after recruitment.
: Not Applicable.
: The authors declare no competing interests.